What Dry Spell? 5AM Closes $200 M Fund
This article was originally published in The Pink Sheet Daily
Executive Summary
As its life-science peers stumble, the early-stage investment firm raises a third fund with 33 percent more committed than its previous fund.
You may also be interested in...
Sidestepping the "Washout," SV Life Sciences Closes $523 Million Fund
The dedicated health care fund says it will stick with its formula: half the fund into biopharma, the other half spread among devices, diagnostics, services, and information technology.
Sidestepping the "Washout," SV Life Sciences Closes $523 Million Fund
The dedicated health care fund says it will stick with its formula: half the fund into biopharma, the other half spread among devices, diagnostics, services, and information technology.
Corporate VCs Star In Financings Of The Fortnight
Probiodrug, Pulmatrix, Virdante all gain new money from corporate ventures.